RESUMEN
BACKGROUND: Autoimmune pulmonary alveolar proteinosis (APAP) is a diffuse lung disease that causes abnormal accumulation of lipoproteins in the alveoli; however, its pathogenesis remains unclear. Recently, APAP cases have been reported during the course of dermatomyositis. The combination of these two diseases may be coincidental; however, it may have been overlooked because differentiating APAP from a flare-up of interstitial pneumonia associated with dermatomyositis is challenging. This didactic case demonstrates the need for early APAP scrutiny. CASE PRESENTATION: A 50-year-old woman was diagnosed with anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatitis and interstitial pneumonia in April 2021. The patient was treated with corticosteroids, tacrolimus, and cyclophosphamide pulse therapy for interstitial pneumonia complicated by MDA5 antibody-positive dermatitis, which improved the symptoms and interstitial pneumonia. Eight months after the start of treatment, a new interstitial shadow appeared that worsened. Therefore, three additional courses of cyclophosphamide pulse therapy were administered; however, the respiratory symptoms and interstitial shadows did not improve. Respiratory failure progressed, and 14 months after treatment initiation, bronchoscopy revealed turbid alveolar lavage fluid, numerous foamy macrophages, and numerous periodic acid-Schiff-positive unstructured materials. Blood test results revealed high anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody levels, leading to a diagnosis of APAP. The patient underwent whole-lung lavage, and the respiratory disturbance promptly improved. Anti-GM-CSF antibodies were measured from the cryopreserved serum samples collected at the time of diagnosis of anti-MDA5 antibody-positive dermatitis, and 10 months later, both values were significantly higher than normal. CONCLUSIONS: This is the first report of anti-MDA5 antibody-positive dermatomyositis complicated by interstitial pneumonia with APAP, which may develop during immunosuppressive therapy and be misdiagnosed as a re-exacerbation of interstitial pneumonia. In anti-MDA5 antibody-positive dermatomyositis, APAP comorbidity may have been overlooked, and early evaluation with bronchoalveolar lavage fluid and anti-GM-CSF antibody measurements should be considered, keeping the development of APAP in mind.
Asunto(s)
Enfermedades Autoinmunes , Dermatitis , Dermatomiositis , Enfermedades Pulmonares Intersticiales , Proteinosis Alveolar Pulmonar , Femenino , Humanos , Persona de Mediana Edad , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico , Proteinosis Alveolar Pulmonar/tratamiento farmacológico , Dermatomiositis/complicaciones , Dermatomiositis/tratamiento farmacológico , Autoanticuerpos , Enfermedades Pulmonares Intersticiales/complicaciones , Enfermedades Pulmonares Intersticiales/diagnóstico , Enfermedades Pulmonares Intersticiales/tratamiento farmacológico , Ciclofosfamida/uso terapéutico , Dermatitis/complicaciones , Helicasa Inducida por Interferón IFIH1RESUMEN
BACKGROUND: To analyze the clinical data and next generation sequencing (NGS) results from a child with 22q11.2 deletion syndrome (22q11DS) complicated with pulmonary alveolar proteinosis (PAP) who was admitted to the Department of Pediatrics of Fuyang People's Hospital and to present a review of the literature. CASE PRESENTATION: A 9-year-old male child, whose face had a small mandible and high-arched palate, but lacked a cleft palate, had repeated respiratory tract infections and bronchiectasis. Clinical examination, computer tomography, and electronic bronchoscopy were performed. Genetic testing via NGS was undertaken. PAP was confirmed by Periodic Acid Schiff staining of milky white alveolar lavage fluid isolated by electronic bronchoscopy. A deletion of approximately 2.46 Mbp on chromosome 22q11.2 was confirmed by NGS. During hospitalization, anti-infection, nebulization, alveolar lavage, and regular application of thymosin were administered to the patient. The condition of the patient stabilized following treatment. CONCLUSIONS: 22q11DS and PAP are both rare diseases, and the manifestation of 22q11DS combined with PAP has not been previously reported. The diagnosis and treatment of this case will be a reference for future clinical work.
Asunto(s)
Fisura del Paladar , Síndrome de DiGeorge , Proteinosis Alveolar Pulmonar , Masculino , Humanos , Niño , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico , Proteinosis Alveolar Pulmonar/genética , Síndrome de DiGeorge/complicaciones , Lavado Broncoalveolar/métodos , Líquido del Lavado Bronquioalveolar , Irrigación TerapéuticaRESUMEN
Pulmonary Alveolar Proteinosis (PAP) is a rare, usually autoimmune, disease, where surfactant accumulates within alveoli due to decreased clearance, causing dyspnea and hypoxemia. The disease is even more rare in pregnancy; nevertheless, it has been reported in pregnant women and can even appear for the first time during pregnancy as an asthma-like illness. Therefore, awareness is important. Similarly to many autoimmune diseases, it can worsen during pregnancy and postpartum, causing maternal and fetal/neonatal complications. This paper offers a narrative literature review of PAP and pregnancy, while illustrating a case of a pregnant patient with known PAP who developed preeclampsia in the third trimester but had an overall fortunate maternal and neonatal outcome.
Asunto(s)
Enfermedades Autoinmunes , Proteinosis Alveolar Pulmonar , Surfactantes Pulmonares , Enfermedades Autoinmunes/complicaciones , Disnea/etiología , Femenino , Humanos , Recién Nacido , Pulmón , Embarazo , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico , Proteinosis Alveolar Pulmonar/terapiaRESUMEN
A 61-year-old patient with cystic bronchiectasis and bronchial artery hyperplasia in the left lung was diagnosed with polymyositis-related interstitial lung disease. After nine months of immunosuppressive therapy, he developed unilateral autoimmune pulmonary alveolar proteinosis (APAP) in the right lung with respiratory failure. After bronchial artery embolization to prevent massive hemoptysis, whole-lung lavage was performed using veno-venous extracorporeal membrane oxygenation. His respiratory condition improved, and he was discharged from the hospital with supplemental oxygen. Three reported cases of APAP with polymyositis-related interstitial lung disease, including the present case, were all positive for anti-glycyl tRNA synthetase antibody and were under immunosuppressive treatment.
Asunto(s)
Aminoacil-ARNt Sintetasas , Enfermedades Pulmonares Intersticiales , Polimiositis , Proteinosis Alveolar Pulmonar , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Autoinmunes , Lavado Broncoalveolar , Enfermedades Pulmonares Intersticiales/complicaciones , Oxígeno , Polimiositis/complicaciones , Polimiositis/diagnóstico , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnósticoRESUMEN
Background: Pulmonary alveolar proteinosis is a very rare diffuse lung disease characterized by the accumulation of amorphous and periodic acid Schiff-positive lipoproteinaceous material in the alveolar spaces due to impaired surfactant clearance by alveolar macrophages. Three main types were identified: Autoimmune, secondary and congenital. Pulmonary alveolar proteinosis has been previously reported to be associated with several systemic auto-immune diseases. Accordingly, we present the first case report of pulmonary alveolar proteinosis associated with myasthenia gravis. Case: A 27-year-old female patient, ex-smoker, developed a dyspnea on exertion in 2020. The chest X-ray detected diffuse symmetric alveolar opacities. Pulmonary infection was ruled out, particularly COVID-19 infection. The chest scan revealed the "crazy paving" pattern. The bronchoalveolar lavage showed a rosy liquid with granular acellular eosinophilic material Periodic acid-Schiff positive. According to the lung biopsy results, she was diagnosed with pulmonary alveolar proteinosis. The granulocyte macrophage colony-stimulating factor autoantibodies were negative. Nine months later, she was diagnosed with bulbar seronegative myasthenia gravis, confirmed with the electroneuromyography with repetitive nerve stimulation showing significant amplitude decrement of the trapezius and spinal muscles. She was treated with pyridostigmine, oral corticosteroids and azathioprine. Given the worsening respiratory condition of the patient, a bilateral whole lung lavage was performed with a partial resolution of symptoms. Thus, this previously unreported association was treated successfully with rituximab, including improvement of dyspnea, diplopia and muscle fatigability at six months of follow-up. Conclusions: This case emphasizes on the possible association of auto-immune disease to PAP, which could worsen the disease course, as the specific treatment does not exist yet. Hence, further studies are needed to establish clear-cut guidelines for PAP management, particularly when associated to auto-immune diseases.
Asunto(s)
Miastenia Gravis , Proteinosis Alveolar Pulmonar , Humanos , Proteinosis Alveolar Pulmonar/terapia , Proteinosis Alveolar Pulmonar/diagnóstico , Proteinosis Alveolar Pulmonar/patología , Proteinosis Alveolar Pulmonar/complicaciones , Femenino , Adulto , Miastenia Gravis/complicaciones , Miastenia Gravis/patologíaRESUMEN
Autoantibodies to multiple cytokines have been identified and some, including antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), have been associated with increased susceptibility to infection. High levels of GM-CSF autoantibodies that neutralize signaling cause autoimmune pulmonary alveolar proteinosis (aPAP), an ultrarare autoimmune disease characterized by accumulation of excess surfactant in the alveoli, leading to pulmonary insufficiency. Defective GM-CSF signaling leads to functional deficits in multiple cell types, including macrophages and neutrophils, with impaired phagocytosis and host immune responses against pulmonary and systemic infections. In this article, we review the role of GM-CSF in aPAP pathogenesis and pulmonary homeostasis along with the increased incidence of infections (particularly opportunistic infections). Therefore, recombinant human GM-CSF products may have potential for treatment of aPAP and possibly other infectious and pulmonary diseases due to its pleotropic immunomodulatory actions.
Asunto(s)
Autoanticuerpos/inmunología , Enfermedades Autoinmunes/inmunología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Infecciones/inmunología , Proteinosis Alveolar Pulmonar/inmunología , Animales , Enfermedades Autoinmunes/complicaciones , Humanos , Proteinosis Alveolar Pulmonar/complicacionesRESUMEN
BACKGROUND: Gastrointestinal lesions, which sometimes develop in Behçet's disease (BD), are referred to as intestinal BD. Although rare, intestinal BD can be accompanied by myelodysplastic syndrome (MDS) with abnormal karyotype trisomy 8, which is refractory to immunosuppressive therapy. Pulmonary alveolar proteinosis is a rare lung complication of BD and MDS. Herein, we present an extremely rare case of intestinal BD presenting with MDS and several chromosomal abnormalities, followed by secondary pulmonary proteinosis. CASE PRESENTATION: A 58-year-old Japanese woman with a 3-year history of genital ulcers and oral aphthae was admitted to our hospital. The patient developed abdominal pain and persistent diarrhea. Colonoscopy revealed multiple, round, punched-out ulcers from the terminal ileum to the descending colon. Intestinal BD was diagnosed and the patient was treated with colchicine, prednisolone, and adalimumab. However, her symptoms were unstable. Bone marrow examination to investigate the persistent macrocytic anemia revealed the presence of trisomy 8, trisomy 9, and X chromosome abnormalities (48, + 8, + 9, X, i(X) (q10) in 12 out of the examined 20 cells). Based on her hypoplastic bone marrow, the patient was diagnosed with low-risk MDS (refractory anemia). At the age of 61, the patient developed pneumonia with fever and diffuse ground-glass opacities on the lung computed tomography (CT). Chest high-resolution CT and histopathology via transbronchial lung biopsy revealed the presence of pulmonary alveolar proteinosis (PAP). These findings combined with the underlying disease led to the diagnosis of secondary PAP. CONCLUSIONS: Secondary pulmonary proteinosis may accompany intestinal BD with MDS and several chromosomal abnormalities. Physicians should pay attention to lung complications, such as PAP, in patients with intestinal BD complicated by MDS. Genetic abnormalities may be associated with the development of such diseases.
Asunto(s)
Síndrome de Behçet , Enfermedades Intestinales , Síndromes Mielodisplásicos , Proteinosis Alveolar Pulmonar , Síndrome de Behçet/complicaciones , Síndrome de Behçet/tratamiento farmacológico , Femenino , Humanos , Persona de Mediana Edad , Síndromes Mielodisplásicos/complicaciones , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico por imagen , TrisomíaRESUMEN
Lung transplantation is an established treatment for a variety of end-stage lung diseases; however, chest wall deformities such as an asymmetric pectus excavatum are often considered a contraindication for lung transplantation. Consequently, the published experience of lung transplants and simultaneous chest wall reconstruction is limited to a few case reports. This article aims to provide a detailed description of surgical steps as well as technical challenges and pitfalls of lung transplantation with a simultaneous modified Ravitch procedure. Exemplary technical aspects will be discussed for a pediatric patient in whom such a combined procedure resulted in an excellent outcome.
Asunto(s)
Tórax en Embudo/cirugía , Trasplante de Pulmón , Proteinosis Alveolar Pulmonar/cirugía , Niño , Femenino , Tórax en Embudo/complicaciones , Humanos , Procedimientos Ortopédicos/métodos , Proteinosis Alveolar Pulmonar/complicaciones , Procedimientos de Cirugía Plástica/métodosRESUMEN
Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis diagnosis). APAP preceded sarcoidosis in the woman, and both diseases were diagnosed simultaneously in the man. Sarcoidosis lesions were observed in the lung, skin, and eyes, and the pathological findings of APAP were not marked at the diagnosis of sarcoidosis in either case. Low-grade positive serum anti-GM-CSF autoantibody was suspected to be correlated with the occurrence of sarcoidosis and resolution of APAP.
Asunto(s)
Autoanticuerpos/sangre , Enfermedades Autoinmunes/complicaciones , Factor Estimulante de Colonias de Granulocitos y Macrófagos/sangre , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/inmunología , Sarcoidosis/etiología , Adulto , Enfermedades Autoinmunes/sangre , Enfermedades Autoinmunes/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteinosis Alveolar Pulmonar/sangre , Proteinosis Alveolar Pulmonar/diagnóstico , Sarcoidosis/fisiopatologíaAsunto(s)
Deficiencia GATA2/complicaciones , Deficiencia GATA2/genética , Factor de Transcripción GATA2/genética , Proteinosis Alveolar Pulmonar/genética , Adulto , Lavado Broncoalveolar/métodos , Distonía/diagnóstico , Femenino , Deficiencia GATA2/diagnóstico , Homocigoto , Humanos , Leucopenia/etiología , Mutación , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/fisiopatología , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico , Proteinosis Alveolar Pulmonar/terapia , Tomografía Computarizada por Rayos X/métodosAsunto(s)
Lavado Broncoalveolar/métodos , Disnea/terapia , Intubación Intratraqueal/métodos , Proteinosis Alveolar Pulmonar/terapia , Lavado Broncoalveolar/instrumentación , Disnea/etiología , Humanos , Lactante , Intubación Intratraqueal/instrumentación , Masculino , Proteinosis Alveolar Pulmonar/complicaciones , Resultado del TratamientoRESUMEN
Idiopathic hypoparathyroidism (IH) and autoimmune pulmonary alveolar proteinosis (PAP) are rare disorders. A patient with IH and optimal calcaemic control on calcium and alfacalcidol was detected to have PAP after 8 years of follow-up. Patient had no respiratory complaints. Routine abdominal imaging for renal calcification showed patchy ground glass opacities in the lower lung fields leading to incidental diagnosis of PAP. Pulmonary function tests showed impaired diffusion capacity of the lung. Anti-granulocyte macrophage-colony stimulating factor autoantibodies were positive. Patient regularly attended the pulmonary clinic and showed progressive improvement in diffusion capacity of the lung during 2 years of follow-up. The calcaemic control in IH remained stable despite its presence with PAP. The autoimmune PAP in the presented case suggests a possible autoimmune basis of IH.
Asunto(s)
Hipoparatiroidismo/complicaciones , Proteinosis Alveolar Pulmonar/complicaciones , Femenino , Humanos , Hipoparatiroidismo/diagnóstico por imagen , Persona de Mediana Edad , Proteinosis Alveolar Pulmonar/diagnóstico por imagen , Pruebas de Función Respiratoria , Tomografía Computarizada por Rayos XRESUMEN
Myelodysplastic syndrome (MDS) is frequently complicated by pulmonary disease. Here, we describe secondary pulmonary alveolar proteinosis (sPAP) that developed during corticosteroid therapy for organising pneumonia (OP) associated with MDS. A 75-year-old woman with MDS complained of cough for 2 weeks. Chest CT showed bilateral patchy consolidations with reversed halo sign. Bronchoalveolar lavage (BAL) examination showed remarkably increased cell density with an increased lymphocyte proportion. Abnormal radiological findings improved rapidly on administration of systemic corticosteroid under the diagnosis of OP; however, they relapsed a few weeks later. Transbronchial lung biopsy showed periodic acid-Schiff stain-positive amorphous materials. Autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) in serum and BAL fluid (BALF) were both negative, while GM-CSF level in BALF was elevated. The patient was diagnosed with sPAP. When chest radiological findings show exacerbation during corticosteroid therapy for OP in a patient with MDS, physicians should consider sPAP complication as a differential diagnosis.
Asunto(s)
Corticoesteroides/efectos adversos , Síndromes Mielodisplásicos/complicaciones , Neumonía/complicaciones , Proteinosis Alveolar Pulmonar/inducido químicamente , Corticoesteroides/uso terapéutico , Anciano , Pueblo Asiatico , Líquido del Lavado Bronquioalveolar/inmunología , Diagnóstico Diferencial , Resultado Fatal , Femenino , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Humanos , Neumonía/diagnóstico por imagen , Neumonía/tratamiento farmacológico , Proteinosis Alveolar Pulmonar/complicaciones , Insuficiencia Respiratoria/etiología , Tomografía Computarizada por Rayos X/métodosAsunto(s)
Disnea/etiología , Proteinosis Alveolar Pulmonar/diagnóstico , Dolor Abdominal/etiología , Tos/etiología , Femenino , Humanos , Dolor de la Región Lumbar/etiología , Pulmón/diagnóstico por imagen , Pulmón/patología , Persona de Mediana Edad , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/diagnóstico por imagen , Proteinosis Alveolar Pulmonar/patología , Tomografía Computarizada por Rayos X , Pérdida de PesoAsunto(s)
Disnea/etiología , Pulmón/patología , Proteinosis Alveolar Pulmonar/diagnóstico , Adulto , Biopsia , Lavado Broncoalveolar , Broncoscopía , Tos/etiología , Diagnóstico Diferencial , Factor Estimulante de Colonias de Granulocitos y Macrófagos/uso terapéutico , Humanos , Hipoxia/etiología , Pulmón/diagnóstico por imagen , Masculino , Neumonía/diagnóstico , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/terapia , Tomografía Computarizada por Rayos XRESUMEN
The methionyl-tRNA synthetase (MARS) mutation is a very rare cause of congenital pulmonary alveolar proteinosis.We report a 6-month-old boy born with symmetrical intrauterine growth retardation presented with unexplained persistent tachypnea and hypoxemia associated with severe failure to thrive, anemia, hypoalbuminemia and hepatomegaly. Detailed pulmonary investigations including computed tomography chest scan, bronchoscopy and bronchoalveolar lavage revealed pulmonary alveolar proteinosis. Whole exome sequencing identified a homozygous novel variant in the MARS gene, c.854T>C p.(Ile285Thr).